AlsaifMFarhatABlumerZ.Budget impact analysis of continuous glucose monitoring in individuals with type 2 diabetes on insulin treatment in England. Health Econ Rev. 2024;14:32. doi:10.1186/s13561-024-00505-7.
2.
AlhaddadAYAlyHGadH, et al. Longitudinal studies of wearables in patients with diabetes: key issues and solutions. Sensors. 2023;23:5003. doi:10.3390/s23115003.
3.
WadwaRPLaffelLMShahVNGargSK.Accuracy of a factory-calibrated, real-time continuous glucose monitoring system during 10 days of use in youth and adults with diabetes. Diabetes Technol Ther. 2018;20(6):395-402. doi:10.1089/dia.2018.0150.
4.
KlonoffDC.The need for separate performance goals for glucose sensors in the hypoglycemic, normoglycemic, and hyperglycemic ranges. Diabetes Care. 2004;27(3):834-836. doi:10.2337/diacare.27.3.834.
5.
International Diabetes Federation. IDF global clinical practice recommendations for managing type 2 diabetes 2025. Accessed February 14, 2026. https://idf.org/t2d-cpr-2025
6.
WilliamsDMParsonsSNDunseathGJStephensJWLuzioSDOwensDR.The impact of structured self-monitoring of blood glucose on glycaemic variability in non-insulin treated type 2 diabetes: the SMBG study, a 12-month randomised controlled trial. Diabetes Metab Syndr. 2020;14(2):101-106. doi:10.1016/j.dsx.2020.01.006.
